Accueil NouvellesLors de ViVE 2024, les panélistes partagent les progrès en matière d’autorisation préalable et les frustrations liées au programme Payer Insights

Lors de ViVE 2024, les panélistes partagent les progrès en matière d’autorisation préalable et les frustrations liées au programme Payer Insights

par naturaladmin
0 comments

Recent discussions at ViVE 2024 highlighted progress in prior authorization processes within the healthcare system, a topic that has long been a source of frustration for medical professionals. Panelists emphasized the need for reforms aimed at reducing the approval time required by insurers for doctors’ coverage requests, reflecting a growing momentum for change across the industry.

However, as advances in policy and technology continue to evolve, stakeholders must navigate the complexities that accompany these changes. Key issues addressed during the sessions included the anticipated effects of the Centers for Medicare and Medicaid Services (CMS) final rule and how it will integrate with state-level policies. The discussion also explored how Application Programming Interfaces (APIs) could further streamline the prior authorization process, providing more context and transparency surrounding payer decisions.

Currently, the U.S. prior authorization landscape is characterized by inconsistent protocols, with optimal scenarios seeing payers respond to physician inquiries in mere minutes. Yet, many doctors express frustration over delayed responses or unclear denials, which can complicate patient care. In response, several states have implemented “gold carding” practices, where physicians with a 90% approval rate for specific services over six months are exempted from prior authorization requirements. Some insurers have eliminated prior authorization for certain medical services, including cataract surgery, physical therapy, and select genetic tests, while various third-party health technology tools aim to expedite the prior authorization process, albeit with mixed success.

The discussion was moderated by Katie Adams, a senior reporter at MedCity News, and included insights from key figures such as:

  • David Dobbs, Vice President and Chief Data Officer at Hawaii Medical Services Administration;
  • Timothy Law, Chief Medical Officer and Vice President of Integrated Care Delivery at Highmark Health;
  • Ginny Whitman, Senior Director of Public Policy at the Alliance of Community Health Plans.

Whitman expressed support for the CMS final rule, particularly its acknowledgment of artificial intelligence’s long-standing role in aiding health plans with prior authorization assessments. She highlighted the potential transformative impact of the new API regulations, expected to be phased in by 2027. “These regulations will not only enhance accessibility for providers but will also promote patient transparency regarding their health plans’ prior authorization metrics,” she stated.

Law described Highmark’s integrated care model as central to their collaboration with providers, allowing for continual feedback on what works and what does not. “This ensures a personalized approach to policy changes based on daily insights,” he noted.

To underscore the importance of prior authorizations, Whitman recounted an instance where an Alliance of Community Health Plans member approved induction requests too early. Following a decision to limit payment for inductions before 36 weeks, practitioners noted improved patient outcomes. “Providers’ perspectives are crucial in forming effective policies and prior authorization protocols,” Whitman remarked.

Law voiced concern over state legislation aimed at significantly reducing prior authorizations. “This approach represents an acceptance of waste that is ethically questionable,” he argued, referencing studies surrounding Medicare’s fee-for-service model that pinpoint significant waste stemming from unnecessary prior authorizations.

Whitman cautioned that while some states seek to grant providers greater autonomy over authorization limitations, this may lead to conflicts with CMS regulations. “It’s crucial to consider that states could enact regulations that conflict with federal guidelines, creating a confusing landscape for healthcare providers and insurers,” she warned.

Photo: Stéphanie Baum, MedCity News

Articles similaires Texte personnalisé

Laisser un commentaire